Group One Trading’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,500
Closed -$2.5K 8225
2025
Q4
$2.5K Buy
+1,500
New +$2.6K ﹤0.01% 7472
2023
Q3
Sell
-2,000
Closed -$2.82K 7988
2023
Q2
$2.82K Hold
2,000
﹤0.01% 6965
2023
Q1
$3K Buy
+2,000
New +$2.79K ﹤0.01% 6493
2022
Q2
Sell
-2,400
Closed -$4K 8182
2022
Q1
$4K Sell
2,400
-13,200
-85% -$20.5K ﹤0.01% 7542
2021
Q4
$38K Buy
15,600
+10,200
+189% +$23.9K ﹤0.01% 6532
2021
Q3
$14K Buy
5,400
+1,600
+42% +$4.11K ﹤0.01% 7354
2021
Q2
$11K Sell
3,800
-4,800
-56% -$12.4K ﹤0.01% 7479
2021
Q1
$20K Buy
8,600
+5,800
+207% +$13.9K ﹤0.01% 6763
2020
Q4
$5K Buy
+2,800
New +$3.92K ﹤0.01% 6020
2019
Q3
Sell
-10,000
Closed -$11K 5357
2019
Q2
$11K Buy
10,000
+4,800
+92% +$5.53K ﹤0.01% 4389
2019
Q1
$7K Buy
+5,200
New +$6.47K ﹤0.01% 4365
2017
Q4
Sell
-34,290
Closed -$85K 5027
2017
Q3
$85K Buy
34,290
+1,829
+6% +$4.53K ﹤0.01% 3334
2017
Q2
$89K Buy
32,461
+10,172
+46% +$28.4K ﹤0.01% 3186
2017
Q1
$67K Buy
22,289
+572
+3% +$1.62K ﹤0.01% 3224
2016
Q4
$69K Buy
+21,717
New +$66.7K ﹤0.01% 3060
2016
Q3
Sell
-9,144
Closed -$21K 4725
2016
Q2
$21K Sell
9,144
-43,663
-83% -$107K ﹤0.01% 3774
2016
Q1
$133K Buy
52,807
+23,690
+81% +$52.9K ﹤0.01% 2622
2015
Q4
$96K Sell
29,117
-90,200
-76% -$270K ﹤0.01% 2990
2015
Q3
$289K Buy
119,317
+32,834
+38% +$85K ﹤0.01% 2227
2015
Q2
$253K Buy
86,483
+28,126
+48% +$109K ﹤0.01% 2362
2015
Q1
$234K Sell
58,357
-21,559
-27% -$74.6K ﹤0.01% 2245
2014
Q4
$241K Sell
79,916
-29,117
-27% -$78.7K ﹤0.01% 2151
2014
Q3
$276K Buy
109,033
+76,199
+232% +$183K ﹤0.01% 2114
2014
Q2
$81K Buy
32,834
+16,107
+96% +$36.4K ﹤0.01% 3186
2014
Q1
$44K Sell
16,727
-30,479
-65% -$89.7K ﹤0.01% 3720
2013
Q4
$137K Buy
47,206
+23,913
+103% +$72.2K ﹤0.01% 2760
2013
Q3
$71K Sell
23,293
-21,188
-48% -$67K ﹤0.01% 3289
2013
Q2
$142K Buy
+44,481
New +$142K ﹤0.01% 2489

Other funds holding LCTX